Betterment LLC’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$399K Buy
434
+9
+2% +$9.12K ﹤0.01% 479
2025
Q4
$457K Buy
+425
New +$406K ﹤0.01% 424

Other funds holding LLY

Betterment LLC's LLY Position: Q1 2026 in Review

Betterment LLC increased its Eli Lilly (LLY) stake by 2.1% in Q1 2026, buying an estimated $9.12K and bringing the position to 434 shares worth $399K. The position accounts for ﹤0.01% of the portfolio, ranked #479.

Betterment LLC first reported a position in LLY in Q4 2025 and has held it in 2 quarters since. The position peaked at $457K in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Betterment LLC held 434 shares of Eli Lilly worth $399K as of Q1 2026.
  • Betterment LLC bought 9 Eli Lilly shares in Q1 2026, an estimated $9.12K.
  • Eli Lilly made up ﹤0.01% of Betterment LLC's portfolio in Q1 2026, its #479 holding.
  • Betterment LLC first reported a position in Eli Lilly in Q4 2025 and has held it in 2 quarters since.
  • Betterment LLC's Eli Lilly position peaked at $457K in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Betterment LLC's 13F filing for Q1 2026, filed 14 May 2026.